Dalton Pharma Services
David Torralbo is a seasoned legal professional with extensive experience in various leadership roles across multiple organizations. Currently serving as the Chairman of the Board (Non-Executive) at Dalton Pharma Services since March 2020, Torralbo also holds the position of Chief Legal Officer at LeddarTech, a role expected to continue until June 2025. Previously, Torralbo was Chief Legal Officer at Nouveau Monde Graphite from January 2021 to June 2022 and served as a Special Advisor (Consultant) for Legal & Corporate Affairs at GDI Integrated Facility Services. Additional experience includes a tenure as Vice-President and Chief Legal Officer at Atrium Innovations, and time spent as a Partner at Davies Ward Phillips & Vineberg LLP, along with associate roles at Clifford Chance and Borden Ladner Gervais LLP. Torralbo holds an LL.L / LL.B from the University of Ottawa and a B.Comm in International Business / Entrepreneurship from McGill University, alongside a DEC in Commerce from Marianopolis College.
This person is not in any teams
This person is not in any offices
Dalton Pharma Services
Dalton is a contract pharmaceutical manufacturer which provides integrated chemistry, development, and manufacturing to biotechnology and pharmaceutical clients around the world. In its 42,000 sq. ft. facility, Dalton operates - cGMP manufacturing of Active Pharmaceutical Ingredients (APIs), - sterile injectables, - finished drug products in vials or syringes - solid oral dosage forms. APIs can be produced in gram to kilogram quantities, including sterile APIs. Dalton contract capabilities can support you at any stage of the regulatory process (Phase I, II, III, or commercial). Development services include - chemistry and process development, - medicinal chemistry, - custom drug conjugation, - targeted drug delivery systems, - analytical method development and validation, - ICH stability testing, - formulation, and - polymorphism screening. Dalton also supports the industry's pharmaceutical research programs with a catalog of 2,500 reference standards, building blocks, metabolites, and impurities with its Dalton Research Molecules division.